Halozyme Therapeutics
HALO
#2402
Rank
A$11.21 B
Marketcap
A$95.34
Share price
0.60%
Change (1 day)
26.07%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$1.15 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.24 Billion. In 2024 the company made an earning of A$0.83 Billion, an increase over its 2023 earnings that were of A$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.15 B38.26%
2024 A$0.83 B59.94%
2023 A$0.52 B39.94%
2022 A$0.37 B0.16%
2021 A$0.37 B92.2%
2020 A$0.19 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$92.75 M-160.48%
2016 -A$0.16 Billion216.03%
2015 -A$48.53 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.13 Billion55.88%
2012 -A$80.63 Million169.94%
2011 -A$29.87 Million-63.44%
2010 -A$81.69 Million-7.19%
2009 -A$88.01 Million15.91%
2008 -A$75.93 Million83.89%
2007 -A$41.3 Million78.1%
2006 -A$23.19 Million16%
2005 -A$19.99 Million45.24%
2004 -A$13.77 Million682.42%
2003 -A$1.76 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MannKind Corp
MNKD
A$46.34 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.87 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.70 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
A$48.77 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA